Professor Eric Solary
Professor Emeritus of Haematology at the Faculty of Medicine of the University of Paris-Saclay, Professor Eric Solary served as the Director of Research at Gustave Roussy from 2011 to February 2020. In this role, he was responsible for integrating clinical, translational, and fundamental research, structuring and managing technological platforms grouped in a mixed-service unit, and coordinating major research programmes focused on molecular medicine, immunotherapy, and DNA repair.
Appointed as Professor of Haematology at the Faculty of Medicine of the University of Burgundy, Eric Solary established the Inserm research unit "Cell Death and Cancer" in 1999 and the Inserm research centre "Lipids, Nutrition, Cancer" in 2007, while also leading the Doctoral School "Biology and Health" and the Federative Research Institute No. 100 within the university. He joined Gustave Roussy in 2007, becoming part of the Haematology Department. He led the Federative Research Institute IRCIV until 2013, the Inserm Unit 1009 until 2014, and the Inserm Unit 1170 until 2020. He also served as the Scientific Director of the Cancéropôle Ile-de-France.
Eric Solary's research focuses on the mechanisms of oncogenesis, with a particular emphasis on myeloid haematological disorders. Within the Inserm Unit 1287 "Haematopoietic Stem Cells and the Development of Myeloid Haematological Disorders," he specifically studies monocytopoiesis and the pathophysiology of chronic myeloid disorders, particularly chronic myelomonocytic leukaemia. His work has contributed to the evolution of diagnostic criteria for the disease within the WHO classification and introduced molecular data into the prognostic stratification of patients. His preclinical studies suggest new therapeutic strategies for this disease, and his team has conducted ancillary studies for several clinical trials dedicated to this condition.
Eric Solary is the author of over 440 publications in international scientific journals. He has received numerous awards, including the Raymond-Rosen Prize from the Foundation for Medical Research in 2018. From 2021 to 2024, he coordinated the European initiative 4.UNCAN.eu, preparing for the sharing of cancer research data within the context of the Health Data Space.
In addition to his research activities, Eric Solary has been a member of the Committee for the Compensation of Victims of Nuclear Tests (CIVEN) under the Prime Minister since 2021 and has been Vice-President of the ARC Foundation for Cancer Research since 2024. He succeeded Jean Feunteun as the Scientific Integrity Officer (RIS) at Gustave Roussy in September 2024.
